Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 11
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 501 | SIEMENS GAMESA RENEWABLE ENERGY A S | 32 | 515.6% | 1 | 26 | 2022–2025 |
| 502 | SONY SEMICONDUCTOR SOLUTIONS | 32 | 39.4% | 4 | 25 | 2022–2025 |
| 503 | THE FURUKAWA BATTERY | 32 | 515.6% | 15 | 12 | 2022–2026 |
| 504 | AJINOMOTO | 31 | 13.2% | 3 | 27 | 2019–2026 |
| 505 | ARCHER AVIATION | 31 | 00% | 0 | 31 | 2023–2026 |
| 506 | ARKEMA | 31 | 00% | 2 | 29 | 2022–2026 |
| 507 | BIOGEN MA | 31 | 39.7% | 2 | 26 | 2021–2025 |
| 508 | BIOHAVEN THERAPEUTICS | 31 | 00% | 3 | 28 | 2022–2026 |
| 509 | CYTIVA BIOPROCESS R D | 31 | 00% | 0 | 31 | 2022–2026 |
| 510 | EVONIK OXENO KG | 31 | 26.5% | 0 | 29 | 2021–2025 |
| 511 | FLAGSHIP PIONEERING INNOVATIONS VI | 31 | 00% | 5 | 26 | 2022–2025 |
| 512 | I4F LICENSING | 31 | 00% | 0 | 31 | 2022–2026 |
| 513 | J C BAMFORD EXCAVATORS | 31 | 13.2% | 0 | 30 | 2020–2026 |
| 514 | JACOBS VEHICLE SYSTEMS | 31 | 412.9% | 1 | 26 | 2022–2026 |
| 515 | KIEKERT AKTIENGESELLSCHAFT | 31 | 00% | 0 | 31 | 2024–2026 |
| 516 | KRONES | 31 | 412.9% | 1 | 26 | 2022–2026 |
| 517 | PPG INDUSTRIES OHIO | 31 | 39.7% | 17 | 11 | 2022–2026 |
| 518 | SAINT GOBAIN ABRASIVES | 31 | 722.6% | 2 | 22 | 2021–2025 |
| 519 | SAP SE | 31 | 412.9% | 0 | 27 | 2020–2025 |
| 520 | SCHNEIDER ELECTRIC IT | 31 | 39.7% | 1 | 27 | 2020–2025 |
| 521 | TOPPAN | 31 | 26.5% | 6 | 23 | 2022–2024 |
| 522 | TOYO SEIKAN | 31 | 412.9% | 5 | 22 | 2022–2026 |
| 523 | ACER | 30 | 413.3% | 0 | 26 | 2022–2025 |
| 524 | BEKAERT | 30 | 00% | 1 | 29 | 2022–2026 |
| 525 | BSH HOUSEHOLD APPLIANCES MANUFACTURING | 30 | 00% | 0 | 30 | 2022–2024 |
| 526 | CNH INDUSTRIAL BRASIL LTDA | 30 | 13.3% | 0 | 29 | 2022–2025 |
| 527 | EMENDOBIO | 30 | 00% | 0 | 30 | 2022–2025 |
| 528 | FU TAI HUA INDUSTRY SHENZHEN | 30 | 00% | 0 | 30 | 2023–2025 |
| 529 | HARMAN INTERNATIONAL INDUSTRIES | 30 | 310% | 2 | 25 | 2019–2025 |
| 530 | HENAN FUCHI TECHNOLOGY | 30 | 00% | 0 | 30 | 2023–2025 |
| 531 | HORIBA | 30 | 00% | 1 | 29 | 2022–2026 |
| 532 | ILLUMINA CAMBRIDGE | 30 | 13.3% | 7 | 22 | 2018–2025 |
| 533 | KROSAKIHARIMA | 30 | 413.3% | 0 | 26 | 2022–2026 |
| 534 | LES LABORATOIRES SERVIER | 30 | 310% | 4 | 23 | 2022–2026 |
| 535 | METSO FINLAND | 30 | 13.3% | 0 | 29 | 2021–2026 |
| 536 | NESTE | 30 | 413.3% | 0 | 26 | 2023–2026 |
| 537 | PRAXAIR TECHNOLOGY | 30 | 1033.3% | 1 | 19 | 2022–2026 |
| 538 | RAYSEARCH LABORATORIES | 30 | 826.7% | 0 | 22 | 2021–2024 |
| 539 | SIEMENS GAMESA RENEWABLE ENERGY INNOVATION TECHNOLOGY S L | 30 | 930% | 0 | 21 | 2022–2025 |
| 540 | BASF MOBILE EMISSIONS CATALYSTS | 29 | 931% | 1 | 19 | 2022–2026 |
| 541 | DAEWOONG PHARMACEUTICAL | 29 | 724.1% | 0 | 22 | 2022–2026 |
| 542 | ENVISION ENERGY | 29 | 26.9% | 0 | 27 | 2022–2026 |
| 543 | GAZTRANSPORT ET TECHNIGAZ | 29 | 413.8% | 0 | 25 | 2020–2026 |
| 544 | METSO OUTOTEC FINLAND | 29 | 310.3% | 2 | 24 | 2022–2023 |
| 545 | MIRATI THERAPEUTICS | 29 | 26.9% | 1 | 26 | 2022–2026 |
| 546 | MUSASHI SEIMITSU INDUSTRY | 29 | 26.9% | 1 | 26 | 2022–2026 |
| 547 | OTSUKA PHARMACEUTICAL FACTORY | 29 | 00% | 0 | 29 | 2022–2026 |
| 548 | SAIC GM WULING AUTOMOBILE | 29 | 13.4% | 0 | 28 | 2020–2026 |
| 549 | SUN PHARMACEUTICAL INDUSTRIES | 29 | 620.7% | 6 | 17 | 2022–2025 |
| 550 | WISDRI ENGINEERING RESEARCH INCORPORATION | 29 | 620.7% | 7 | 16 | 2022–2025 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →